bin yu
Zhengzhou University
Zhengzhou, China
Associate Editor
Anti-Cancer Drugs
Type at least 3 characters
722 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
shuguang yuan
AlphaMol Science Ltd
Shenzhen, China
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
hanting zhang
Department of Pharmacology, School of Pharmacy, Qingdao University
Qingdao, China
Associate Editor
Neurological Drugs
jian-ye zhang
Guangzhou Medical University
Guangzhou, China
Associate Editor
Anti-Cancer Drugs
xuechu zhen
College of Pharmaceutical Sciences, Soochow University Medical College
Suzhou, China
Associate Editor
Neurological Drugs
haibing zhou
Wuhan University
Wuhan, China
Associate Editor
Anti-Cancer Drugs
Review Editors
sergi herve akone
University of Douala
Douala, Cameroon
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
enes akyuz
University of Wisconsin-Madison
Madison, United States
Review Editor
Neurological Drugs
ahm alam
University of Rajshahi
Rajshahi, Bangladesh
Review Editor
Anti-Cancer Drugs
patrick auberger
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Anti-Cancer Drugs
mohamed diwan m abdulhameed
Biotechnology HPC Software Applications Institute (BHSAI)
Frederick, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
tigran abramyan
Atomwise Inc
San Francisco, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
michael adikwu
University of Nigeria, Nsukka
Nsukka, Nigeria
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
george w agak
David Geffen School of Medicine, University of California, Los Angeles
Los Angeles, United States
Review Editor
Dermatologic Drugs
anna caroline aguiar
Federal University of São Paulo
São Paulo, Brazil
Review Editor
Anti-Infective Agents
othman al musaimi
Imperial College London
London, United Kingdom
Review Editor
Anti-Infective Agents